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Additional Sources 
Case Presentation 
     Surveillance imaging for her FNH  
noted a small, cystic lesion in the body of 
the pancreas measuring 0.6 centimeters. 
No follow up was done for this lesion.  
     In 2014 surveillance imaging, the 
patient’s pancreatic cyst had increased 
in size to one centimeter and new 
pancreatic duct dilation and irregularity 
was described, as well as an appearance 
of chronic pancreatitis. Mild symptoms 
were present at this time, including 
abdominal cramping and bloating. No 
jaundice, weight loss or fatigue were 
reported.  
     She underwent an endoscopic 
ultrasound at this time, which 
demonstrated no significant abnormality 
in the pancreas.  An abrupt change in the 
distal body and tail, distal to a focal 
calcification was described. This was 
suggestive of inflammation. Cysts 
measuring as large as 12 mm were 
noted, and fine needle aspiration was 
performed. The fluid was thin and 
blood-tinged.  
     Cytology results demonstrated no 
evidence of malignancy or mucin, and 
cyst fluid analysis for amylase and CEA 
were unable to be performed due to an 
inadequate amount of fluid.  
     The patient was seen in surgical 
consultation and elected to undergo the 
recommended surgical resection via 
distal pancreatecomy with splenectomy.    
     Final pathology revealed a 1.5 
centimeter pancreatic tumor positive for 
moderately differentiated pancreatic 
ductal adenocarcinoma arising in 
intraductal pancreatic mucinous 
neoplasm with high-grade dysplasia 
involving the main duct and branches 
(mixed type). Of the 14 lymph nodes that 
were evaluated, zero were positive for 
adenocarcinoma.  
     Intraductal papillary mucinous 
neoplasms (IPMN) are uncommon 
tumors arising from the main pancreatic 
duct, branching pancreatic ducts, or both. 
The “overall incidence of invasive 
carcinoma associated with resected IPMN 
has been reported to be 20-40%” (Mohri 
et al., 2011). Due to their malignant 
potential, these lesions, along with 
mucinous cystic neoplasms (MCN), are 
considered more worrisome, and often 
require surgical resection (Gallucci, 
Langellotto, De Ritis, & Uomo, 2012).    
     Even after removal of a primary lesion, 
patients remain under surveillance to 
monitor for recurrence, the rate of which 
is approximately 6 %  (Gallucci et al., 
2012), and patients with main duct IPMN 
are at a higher risk for developing 
pancreatic , gastric and colon 
adenocarcinoma over their lifetimes   
(Sheth, Howell & Kent, 2014). 
While both main duct and side branch 
lesions are considered pre-malignant, 
management of IPMN has not been well-
established (Mohri et al., 2011) and 
ranges from watchful waiting to surgical 
resection, depending upon the suspicion 
of malignancy, the operation required 
and the relative risk to the patient. A 
lower threshold for surgical resection is 
present for main duct IPMNs, as they 
have a higher risk of associated 
malignancy (Sahora & Castillo, 2014). 
     The incidence of pancreatic 
adenocarcinoma arising from IPMN has 
been well documented (Mohri et al., 
2011). This poster discusses one such 
case. The patient’s IPMN was initially 
discovered incidentally, during 
evaluation of an unrelated medical 
diagnosis.  
     As practitioners, it is important to be 
able to recognize IPMN as pre-malignant 
lesions and to act quickly to identify 
patients requiring further work-up. Since 
the prognosis of pancreatic 
adenocarcinoma is dismal,  the early 
identification and treatment of IPMN, or 
pre-malignant lesions is imperative to  
improve outcomes (Mohri et al., 2011). 
      
     Patients with main duct and side 
branch IPMNs are often asymptomatic. 
Symptoms can include, abdominal 
discomfort and/or distress, vomiting, 
back pain, or signs of chronic 
pancreatitis (Grützmann, Post, Saeger, & 
Niedergethmann, 2011). Though 
uncommon, IPMN can cause mild acute 
pancreatitis (Jang et al., 2013). 
Symptoms predictive of malignancy 
include jaundice, weight loss or diabetes 
(Gallucci et al., 2012).  
     Radiographic evidence of IPMN 
includes the presence of a cystic lesion 
with a dilated main duct and evidence of 
communication between the cyst and the 
duct. MRI is more sensitive for detecting 
a mural nodule, which is considered a 
“strong predictive factor for malignancy” 
(Uehara et al., 2011).  
     Signs of IPMN on endoscopic 
ultrasonography include the presence of 
papillary growth in the ducts of the 
pancreas, communication between the 
cyst and the duct (either main or 
branch), and/or a clearly dilated main 
duct (Grutzmann et al., 2011) with or 
without the presence of mucin within 
the duct. (Gallucci et al., 2012). Presence 
of mucin in the duct can have the classic 
“fish eye” appearance. Fine needle 
aspiration often demonstrates atypical 
cells or mucin, and laboratory evaluation 
of CEA levels greater than 2500 ng/mL 
are considered diagnostic. (Grutzmann 
et al., 2011) . 
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Endoscopic Ultrasound often shows mucin arising from the main pancreatic duct, 
giving a “fish eye” appearance.  
     IPMNs are precursors to invasive 
pancreatic adenocarcinoma. Recognizing 
their clinical significance is essential in 
practice and educating patients about 
their implication is a responsibility of the 
practitioner. Management of these 
premalignant lesions varies greatly 
depending upon subtype, patient age, 
comorbidities and morbidity of required 
surgery. Close surveillance with MRI and a 
multidisciplinary approach may be the 
preferred management for some patients, 
particularly those without suspicious 
findings (Roch et al., 2014). 
 
Conclusion 
     IPMNs arise from the pancreatic ductal 
epithelium. The columnar epithelial 
tumor cells secrete mucin, leading to the 
dilation of the pancreatic duct and the 
associated symptoms of abdominal pain 
and pancreatitis. Intraductal papillary 
growth is also present.  Cellular changes 
within the IPMN can vary from slight 
mucinous hyperplasia to invasive 
adenocarcinoma (Capurso et al., 2013).  
The cause of the development of IPMN is 
not fully understood., though they have 
been linked to several molecular changes. 
Pathophysiology of IPMN 
     According to Gallucci et al. (2012) 
mutation of K-ras, an oncogene responsible 
for regulating the division of cells, is 
present in up to 65% of IPMNs.  Other 
molecular abnormalities include alterations 
in CDKN2a, ring finger protein 43 gene,  
SMAD4, STK11, MUC1, 2, and 5, and 
promoter sequence hypermethylation 
(Sheth, Howell & Kent, 2014). 
     The pathophysiology of IPMN is 
significant because the cellular changes are 
often atypical and can progress to an 
invasive pancreatic adenocarcinoma, the 5-
year survival rate of which is 1-14% 
(American Cancer Society, 2014). 
Possible Molecular Abnormalities in IPMN 
     As advanced practice nurses, it is 
important to consider incidental imaging 
findings and their clinical significance. In 
the case of incidental pancreatic findings, 
referral to pancreatologists or surgical 
oncologists is critical, as early detection 
of premalignant lesions will lead to 
increases in survival for many patients. 
Attention to vague symptoms, such as 
persistent abdominal complaints should 
be followed closely and IPMN should be 
in the differential diagnosis, especially 
when other causes have been ruled out.  
     Additional consideration should also 
be given to patients with a history of 
IPMN. Given their overall increased risk 
of both colon and gastric cancer, routine 
screenings, including upper and lower 
endoscopy, should be considered for 
these patients, though they may not be 
the recommended age for such testing.  
The cystic structure in the distal pancreas appears to arise from the main 
pancreatic duct.  
  The patient is a 51 year-old female who 
was noted to have multiple liver lesions 
at the time of imaging for her 
cholecystectomy several years ago. She 
was under surveillance for these liver 
lesions, which were felt to be focal 
nodular hyperplasia (FNH).  
Signs & Symptoms 
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Margins were negative. The final staging 
was T1N0 (stage IA). The patient was 
referred to medical oncology and 
chemotherapy was recommended.  
• K-ras: Responsible for normal tissue signaling, K-ras is a protein that binds to 
GTP and referees signal transduction. Mutations in K-ras is present in up to 65% 
of IPMNs.  
• CDKN2a: Mutations in this tumor suppressor gene have  been associated with 
IPMN. 
• Ring finger protein 43: This protein plays a role in  suppressing mucus 
producing neoplasia of the pancreas. Mutations that inactivate this gene have 
been associated with IPMN.  
• SMAD4: Intracellular proteins that code and transcribe extracellular signals in 
the nucleus. Expression of SMAD4 is present in most IPMNs. 
• STK11: This gene, which acts as a tumor suppressor, is mutated in patients with 
Peutz-Jeghers syndrome. A subset of these patients have a higher risk of both 
IPMN and pancreatic cancer. 
• MUC: These mucin mRNA, particularly MUC 1,2, and 5are highly expressed in 
approximately 86% of IPMN. MUC1 and MUC2 are associated with malignancy. 
• Promoter sequence hypermethylation: This process can cause gene silencing. 
Hypermethylation of tumor suppressor genes has been seen in patients with 
IPMN with greater degrees of dysplasia or even cancer. 
(Sheth, Howell & Kent, 2014) 
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